| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/28/2007 | EP1443931B1 Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities |
| 03/28/2007 | EP1254944B1 Dry compositions containing hydrophobic amino acid |
| 03/28/2007 | EP1229933B1 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 03/28/2007 | EP1228071B1 Pharmaceutically active isoindoline derivatives |
| 03/28/2007 | EP1064947B1 In ovo vaccination of marek's disease virus type 1 |
| 03/28/2007 | EP0908182B2 Preventives or remedies for diseases induced by hypofunction of nitric oxide synthase (nos) |
| 03/28/2007 | CN1938318A Process for producing flavone C glycoside derivatives |
| 03/28/2007 | CN1938307A 9-substituted 8-oxoadenine compound |
| 03/28/2007 | CN1938045A Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 03/28/2007 | CN1938019A Protein kinase C inhibitors for the treatment of autoimmune diseases and of transplant rejection |
| 03/28/2007 | CN1938018A Use of compounds that are able to increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 03/28/2007 | CN1938014A Solid preparation containing dibenz[b,e]oxepine derivative |
| 03/28/2007 | CN1936001A Goose B lymphocyte stimulating factor CDNA, and its cloning method and recombinant use |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935235A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935234A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935233A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935232A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935231A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935230A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935229A Chinese medicine injection preparation and its preparing method |
| 03/28/2007 | CN1935182A Chinese herbal medicine compound immunopotentiator for animal |
| 03/28/2007 | CN1935156A Remedy |
| 03/28/2007 | CN1935155A Remedy |
| 03/28/2007 | CN1935141A Compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 03/28/2007 | CN1935135A Effective fraction medicine for treating lupus erythematosus |
| 03/28/2007 | CN1307197C Heterosides peptide injection liquor for improving animal immunological function |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307179C Pyrimidine derivatives for inhibition of cell proliferation |
| 03/28/2007 | CN1307176C Novel alkoxypyridine-derivatives |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307159C TNF-alpha prodn. inhibitors |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
| 03/28/2007 | CN1306941C Skin preparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196195 8-chloro-6,11-dihydro-11-(4-piperidilydene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine); good solubility; anti-allergen |
| 03/27/2007 | US7196192 28-epirapalogs |
| 03/27/2007 | US7196181 made in non-thyroidal eukaryotic cells; for diagnosis and treatment of immune disorders such as Hashimoto's thyroiditis |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196101 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases |
| 03/27/2007 | US7196092 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196077 Tachykinin antagonists |
| 03/27/2007 | US7196073 polysaccharide binding to surface receptor on antigen presenting cells |
| 03/27/2007 | US7195906 probiotics having immunomodulatory activity, used for prophylaxis gastrointestinal disorders such as inflammatory bowel disease or irritable bowel syndrome |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | CA2391953C Nervonic acid derivatives, their preparation and use |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2198727C Cell growth regulator |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/27/2007 | CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives |
| 03/22/2007 | WO2007032556A1 Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2007032445A1 Protein kinase inhibitors |
| 03/22/2007 | WO2007031996A1 Compositions and methods for diagnosing and treating an inflammation |
| 03/22/2007 | WO2007031832A2 Use of bipyridine compound 'caerulomycin a' derivatives and analogs thereof as immunosuppressive agents |
| 03/22/2007 | WO2007031726A1 Purine derivatives having immuno-modulating properties |
| 03/22/2007 | WO2007015004A3 Novel crystalline v form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 03/22/2007 | WO2006134385A3 Anti-inflammatory agents |
| 03/22/2007 | WO2006002909A3 Sphingolipids against pathological processes in lipid rafts |
| 03/22/2007 | WO2005054264A3 Glycomimetic antagonists for both e- and p-selectins |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066804 Polypeptide of given sequence; inducing HLA (human leukocyte antigen) restricted cytotoxic T lymphocytes |
| 03/22/2007 | US20070066639 Oxime substituted imidazoquinolines |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 03/22/2007 | US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide |
| 03/22/2007 | US20070066564 Sulfotransferase inhibitor |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066553 Immunostimulatory nucleic acid molecules |
| 03/22/2007 | US20070066523 Chemokine analogs for the treatment of human diseases |
| 03/22/2007 | US20070066515 Novel glycoprotein and pharmaceutical composition containing the same |
| 03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065467 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 03/22/2007 | US20070065465 Conjugate vaccines for the prevention of dental caries |
| 03/22/2007 | US20070065451 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
| 03/22/2007 | US20070065435 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065434 Gamma-1 And Gamma-3 Anti-Human CD23 Monoclonal Antibodies And Use Thereof As Therapeutics |
| 03/22/2007 | US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging |
| 03/22/2007 | US20070065369 Bioavailability; delivery to deep lung; lipid based microstructure; rapid release and absorption |
| 03/22/2007 | CA2625815A1 Anti-cd3 antibody formulations |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/22/2007 | CA2621248A1 Anti-human sr-b1 antibody reducing inflammation and treating auto-immunedisease |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764091A2 Improvements in or relating to amphoteric liposomes |
| 03/21/2007 | EP1763342A2 Sphingolipids against pathological processes in lipid rafts |
| 03/21/2007 | EP1539752B1 Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via novel imidazo[4,5-c]quinolin-4-cyano and 1h-imidazo[4,5-c]quinolin-4-carboxamide intermediates |
| 03/21/2007 | EP1515710B1 Method of treating rosacea by topical application of a cyclohexane derivative |